Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	axonemal dynein complex	DNAH7 NME8 CFAP70 DNAI7	2.31e-05	25	142	4	GO:0005858
GeneOntologyCellularComponent	collagen-containing extracellular matrix	SERPINA3 COL6A2 PSAP WNT8A LAMA1 COL6A5 OGN FBN2 LOX ACAN LPA PZP USH2A	6.84e-05	530	142	13	GO:0062023
GeneOntologyCellularComponent	postsynaptic membrane	CACNA2D1 CLSTN2 NLGN1 GRIN2C CSMD2 TENM2 CHRNA1 OPRK1 KCNC3 FLRT3 SEZ6L	1.04e-04	405	142	11	GO:0045211
GeneOntologyCellularComponent	glutamatergic synapse	FLNA CACNA2D1 CLSTN2 NLGN1 GRIN2C CSMD2 TENM2 KCNC3 ACAN LPA ARHGAP44 PLXNA4 AP3M2 FLRT3 RIMS2 SEZ6L	1.40e-04	817	142	16	GO:0098978
GeneOntologyCellularComponent	extracellular matrix	SERPINA3 COL6A2 PSAP WNT8A LAMA1 COL6A5 OGN FBN2 LOX ACAN LPA FLRT3 PZP USH2A	1.56e-04	656	142	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	SERPINA3 COL6A2 PSAP WNT8A LAMA1 COL6A5 OGN FBN2 LOX ACAN LPA FLRT3 PZP USH2A	1.61e-04	658	142	14	GO:0030312
GeneOntologyCellularComponent	dynein complex	DNAH7 NME8 CFAP70 DNAI7	4.96e-04	54	142	4	GO:0030286
GeneOntologyCellularComponent	synaptic membrane	CACNA2D1 CLSTN2 NLGN1 GRIN2C CSMD2 TENM2 CHRNA1 OPRK1 KCNC3 FLRT3 RIMS2 SEZ6L	6.41e-04	583	142	12	GO:0097060
GeneOntologyCellularComponent	ubiquitin ligase complex	DCAF15 RNF217 RBCK1 FBH1 ANAPC1 ARIH2 FBXW5 ANKIB1 KLHL12	6.90e-04	352	142	9	GO:0000151
GeneOntologyCellularComponent	cytoplasmic region	DNAH7 NME8 HNRNPU AGBL4 CFAP54 AP3M2 CFAP70 DNAI7 RIMS2	8.09e-04	360	142	9	GO:0099568
GeneOntologyCellularComponent	transferase complex	DCAF15 INSR SMC6 REV3L EZH2 RNF217 RBCK1 FBH1 ANAPC1 ARIH2 FBXW5 ANKIB1 MMS19 KLHL12 TADA3 KDM6A	8.58e-04	963	142	16	GO:1990234
GeneOntologyCellularComponent	melanosome	SLC24A5 ANKRD27 FASN ATP1A1 SYTL1	1.05e-03	113	142	5	GO:0042470
GeneOntologyCellularComponent	pigment granule	SLC24A5 ANKRD27 FASN ATP1A1 SYTL1	1.05e-03	113	142	5	GO:0048770
GeneOntologyCellularComponent	sarcoplasm	CACNA2D1 FLNC CHERP NOX4 OPRK1	1.09e-03	114	142	5	GO:0016528
GeneOntologyCellularComponent	cilium	TNPO1 UNC119B DNAH7 NME8 AGBL4 PROM1 CFAP54 CCDC66 AJM1 PCDH11X CFAP70 DNAI7 ATP1A1 EFCAB7 USH2A	1.19e-03	898	142	15	GO:0005929
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH7 NME8 HNRNPU AGBL4 CFAP54 AP3M2 CFAP70 DNAI7	1.48e-03	317	142	8	GO:0032838
GeneOntologyCellularComponent	sarcolemma	COL6A2 CACNA2D1 FLNC OBSCN OPRK1 ATP1A1	1.92e-03	190	142	6	GO:0042383
GeneOntologyCellularComponent	inner dynein arm	DNAH7 DNAI7	1.99e-03	10	142	2	GO:0036156
Domain	HEAT	TNPO1 TNPO2 NCAPG MMS19 HEATR3 KPNB1	1.51e-06	48	140	6	PF02985
Domain	IBR	RNF217 RBCK1 ARIH2 ANKIB1	2.86e-06	14	140	4	PF01485
Domain	IBR_dom	RNF217 RBCK1 ARIH2 ANKIB1	3.87e-06	15	140	4	IPR002867
Domain	HEAT	TNPO1 TNPO2 NCAPG MMS19 HEATR3 KPNB1	4.68e-06	58	140	6	IPR000357
Domain	HEAT_REPEAT	TNPO1 TNPO2 NCAPG MMS19 HEATR3 KPNB1	1.41e-05	70	140	6	PS50077
Domain	E3_UB_ligase_RBR	RNF217 ARIH2 ANKIB1	4.76e-05	10	140	3	IPR031127
Domain	Ig_E-set	UNC119B FLNA FLNC NFATC3 PLXNA4 PLXNB1	1.32e-04	104	140	6	IPR014756
Domain	IMPORTIN_B_NT	TNPO1 TNPO2 KPNB1	1.41e-04	14	140	3	PS50166
Domain	IBR	RNF217 ARIH2 ANKIB1	1.41e-04	14	140	3	SM00647
Domain	IBN_N	TNPO1 TNPO2 KPNB1	1.76e-04	15	140	3	PF03810
Domain	IBN_N	TNPO1 TNPO2 KPNB1	2.15e-04	16	140	3	SM00913
Domain	Importin-beta_N	TNPO1 TNPO2 KPNB1	2.60e-04	17	140	3	IPR001494
Domain	DUF2476	PRR23B PRR23C	3.31e-04	4	140	2	PF10630
Domain	PRR23	PRR23B PRR23C	3.31e-04	4	140	2	IPR018903
Domain	-	FLNA FLNC INSR OBSCN IL20RB NFATC3 NEGR1 UNC5C PLXNA4 SIGLEC1 FLRT3 USH2A ALPK2 PLXNB1	4.65e-04	663	140	14	2.60.40.10
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	CACNA2D1 FLNC CHERP ECD UBR4 LAMA1 RBCK1 ATP6V0D1 ANKIB1 ATP11C MMS19 KLHL12	8.89e-09	313	145	12	38270169
Pubmed	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR.	TNPO1 TNPO2 KPNB1	2.83e-07	4	145	3	15037768
Pubmed	Large-scale analysis of the human ubiquitin-related proteome.	UBR4 LAMA1 PFKFB2 HNRNPU SPRYD7 ATP6V0D1 SLC25A13 ANKIB1 KLHL12 KPNB1	8.53e-07	313	145	10	16196087
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MYC TNPO1 UBR4 SMC6 GTF3C6 FASN RBM25 NCAPG CLIC1 ANAPC1 ARIH2 MEPCE HTATSF1 MMS19 TADA3 KDM6A	5.59e-06	1014	145	16	32416067
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	SERPINA3 COL6A2 LAMA1 COL6A5 OGN LOX LPA	6.87e-06	167	145	7	22159717
Pubmed	Functional consequences of necdin nucleocytoplasmic localization.	TNPO1 TBC1D9 CCM2 TADA3 KPNB1	7.35e-06	64	145	5	22442722
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	SERPINA3 COL6A2 LAMA1 COL6A5 OGN FBN2 LPA	9.33e-06	175	145	7	28071719
Pubmed	Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.	PFKFB2 MYSM1 HNRNPU SPRYD7 ATP6V0D1 SLC25A13 KPNB1	1.12e-05	180	145	7	21139048
Pubmed	Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.	FLNC EZH2 USH2A	1.14e-05	11	145	3	24349473
Pubmed	UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.	EZH2 KDM6A	1.73e-05	2	145	2	29045832
Pubmed	USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc.	MYC USP16	1.73e-05	2	145	2	33546726
Pubmed	Programmed cell senescence in skeleton during late puberty.	EZH2 KDM6A	1.73e-05	2	145	2	29101351
Pubmed	ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.	MYC TADA3	1.73e-05	2	145	2	27852327
Pubmed	Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.	MYC EZH2	1.73e-05	2	145	2	35596973
Pubmed	Mapping of two genes encoding isoforms of the actin binding protein ABP-280, a dystrophin like protein, to Xq28 and to chromosome 7.	FLNA FLNC	1.73e-05	2	145	2	7689010
Pubmed	Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.	MYC FASN	1.73e-05	2	145	2	33187130
Pubmed	Histone Demethylase UTX is an Essential Factor for Zygotic Genome Activation and Regulates Zscan4 Expression in Mouse Embryos.	MYC KDM6A	1.73e-05	2	145	2	31595154
Pubmed	Filamin isogene expression during mouse myogenesis.	FLNA FLNC	1.73e-05	2	145	2	10679933
Pubmed	The c-MYC transcription factor conduces to resistance to cisplatin by regulating MMS19 in bladder cancer cells.	MYC MMS19	1.73e-05	2	145	2	37201439
Pubmed	Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels.	REST KCNQ4	1.73e-05	2	145	2	23242999
Pubmed	Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins.	TNPO1 TNPO2	1.73e-05	2	145	2	9298975
Pubmed	Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.	MYC REST	1.73e-05	2	145	2	16478988
Pubmed	EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.	EZH2 KDM6A	1.73e-05	2	145	2	24123378
Pubmed	A novel structural unit in the N-terminal region of filamins.	FLNA FLNC	1.73e-05	2	145	2	24469451
Pubmed	A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.	FLNC OBSCN	1.73e-05	2	145	2	29073160
Pubmed	Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities.	IL12A INSR	1.73e-05	2	145	2	22428016
Pubmed	Repressor element 1-silencing transcription factor deficiency yields profound hearing loss through Kv7.4 channel upsurge in auditory neurons and hair cells.	REST KCNQ4	1.73e-05	2	145	2	36125121
Pubmed	Transportin-1 and Transportin-2: protein nuclear import and beyond.	TNPO1 TNPO2	1.73e-05	2	145	2	24780099
Pubmed	A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.	MYC EZH2	1.73e-05	2	145	2	24802772
Pubmed	EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.	MYC EZH2	1.73e-05	2	145	2	37147437
Pubmed	Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.	MYC EZH2	1.73e-05	2	145	2	21941025
Pubmed	Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway.	FLNA INSR	1.73e-05	2	145	2	12734206
Pubmed	Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.	EZH2 KDM6A	1.73e-05	2	145	2	28228601
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	TNPO1 ANAPC1 ARIH2 HTATSF1 MMS19 KPNB1	1.77e-05	129	145	6	23022380
Pubmed	Gene expression analysis of the embryonic subplate.	CACNA2D1 NCAPG CLIC1 UNC5C PLXNA4 FLRT3 ATP1A1	1.94e-05	196	145	7	21862448
Pubmed	Global identification of modular cullin-RING ligase substrates.	PFKFB2 MYSM1 HNRNPU SPRYD7 ATP6V0D1 KPNB1	2.19e-05	134	145	6	21963094
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	WNT8A REST EZH2 USP16 GTF3C6 NCAPG HTATSF1 CRYBG1 KDM6A KPNB1	2.95e-05	469	145	10	27634302
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	TNPO1 FLNA FLNC PSAP SMC6 HNRNPU FASN RBM25 C17orf75 ANAPC1 HTATSF1 ALPK2 KPNB1	3.67e-05	809	145	13	32129710
Pubmed	Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.	MYC FLNA CHERP ECD SYTL1 TADA3	3.83e-05	148	145	6	22898364
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	TNPO1 FLNA FLNC INSR HNRNPU FASN NCAPG SLC25A13 ATP1A1 KPNB1	3.84e-05	484	145	10	31995728
Pubmed	RAB-like 2 has an essential role in male fertility, sperm intra-flagellar transport, and tail assembly.	TNPO1 SERPINA3 FLNA TNPO2 KPNB1	4.32e-05	92	145	5	23055941
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	UBR4 RBCK1 ARIH2 ANKIB1 HERC4	5.04e-05	95	145	5	29643511
Pubmed	ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.	MYC ARHGAP44	5.16e-05	3	145	2	38031136
Pubmed	Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules.	TNPO1 KPNB1	5.16e-05	3	145	2	12614157
Pubmed	Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.	FBN2 LOX	5.16e-05	3	145	2	12750963
Pubmed	The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties.	TNPO1 KPNB1	5.16e-05	3	145	2	9430704
Pubmed	EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.	EZH2 KPNB1	5.16e-05	3	145	2	24132643
Pubmed	Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.	MYC EZH2	5.16e-05	3	145	2	24499724
Pubmed	miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.	MYC EZH2	5.16e-05	3	145	2	30166592
Pubmed	BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer.	MYC EZH2	5.16e-05	3	145	2	26939702
Pubmed	Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin.	FLNA FLNC	5.16e-05	3	145	2	11038172
Pubmed	EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.	EZH2 KDM6A	5.16e-05	3	145	2	31285428
Pubmed	Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin.	FLNA FLNC	5.16e-05	3	145	2	11102480
Pubmed	Identification of a karyopherin β1/β2 proline-tyrosine nuclear localization signal in huntingtin protein.	TNPO1 KPNB1	5.16e-05	3	145	2	23012356
Pubmed	Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm.	FLNA FLNC	5.16e-05	3	145	2	17825253
Pubmed	Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.	EZH2 KDM6A	5.16e-05	3	145	2	21828135
Pubmed	Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.	MYC EZH2	5.16e-05	3	145	2	28329683
Pubmed	MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.	MYC EZH2	5.16e-05	3	145	2	23135913
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNA FLNC	5.16e-05	3	145	2	12393796
Pubmed	Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.	EZH2 KDM6A	5.16e-05	3	145	2	21865393
Pubmed	Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways.	TNPO1 KPNB1	5.16e-05	3	145	2	12551970
Pubmed	Cytoskeletal protein ABP-280 directs the intracellular trafficking of furin and modulates proprotein processing in the endocytic pathway.	FLNA FLNC	5.16e-05	3	145	2	9412467
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNA FLNC	5.16e-05	3	145	2	11153914
Pubmed	Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.	EZH2 KPNB1	5.16e-05	3	145	2	25890085
Pubmed	The histone demethylase Utx controls CD8+ T-cell-dependent antitumor immunity via epigenetic regulation of the effector function.	EZH2 KDM6A	5.16e-05	3	145	2	37068788
Pubmed	The Asprosin-OLFR734 hormonal signaling axis modulates male fertility.	OR4M1 OR4M2	5.16e-05	3	145	2	31798959
Pubmed	Filamins as integrators of cell mechanics and signalling.	FLNA FLNC	5.16e-05	3	145	2	11252955
Pubmed	The F-actin cross-linking and focal adhesion protein filamin A is a ligand and in vivo substrate for protein kinase C alpha.	FLNA FLNC	5.16e-05	3	145	2	12704190
Pubmed	Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway.	MYC INSR	5.16e-05	3	145	2	29518496
Pubmed	Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC.	IL12A SIGLEC1	5.16e-05	3	145	2	19950173
Pubmed	lncRNA PVT1 promotes hepatitis B virus‑positive liver cancer progression by disturbing histone methylation on the c‑Myc promoter.	MYC EZH2	5.16e-05	3	145	2	31894346
Pubmed	EZH2 expression is dependent on MYC and TP53 regulation in diffuse large B-cell lymphoma.	MYC EZH2	5.16e-05	3	145	2	31991488
Pubmed	The Asprosin-OLFR734 module regulates appetitive behaviors.	OR4M1 OR4M2	5.16e-05	3	145	2	32337066
Pubmed	hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.	MYC HNRNPU	5.16e-05	3	145	2	19578763
Pubmed	ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.	TNPO1 TNPO2	5.16e-05	3	145	2	20606625
Pubmed	Mechanism of hsp70i gene bookmarking.	NCAPG HSF2	5.16e-05	3	145	2	15662014
Pubmed	Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.	MYC PROM1	5.16e-05	3	145	2	22945648
Pubmed	Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.	MYC EZH2	5.16e-05	3	145	2	23538750
Pubmed	Involvement of transportin 2-mediated HuR import in muscle cell differentiation.	TNPO1 TNPO2	5.16e-05	3	145	2	17475777
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	TNPO1 FLNA REST FASN NCAPG SLC25A13 ATP1A1 KPNB1	6.29e-05	320	145	8	28685749
Pubmed	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.	MYSM1 HNRNPU SPRYD7 ATP6V0D1 SLC25A13 KPNB1	6.34e-05	162	145	6	21890473
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TNPO2 UBR4 LAMA1 OBSCN REV3L CSMD2 HNRNPU MROH8 PLXNA4 PWWP3B HEATR3 DSE	6.43e-05	736	145	12	29676528
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	UNC5C PLXNA4 FLRT3 PLXNB1	6.72e-05	52	145	4	26633812
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	CACNA2D1 PSAP OBSCN HNRNPU PROM1 FASN C17orf75 ATP6V0D1 CLIC1 LOX SLC25A13 PLXNA4 ATP1A1	6.73e-05	859	145	13	31536960
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MYC TNPO1 FLNA FLNC CHERP HNRNPU ORC1 FASN RBM25 CLIC1 SLC25A13 MEPCE ATP1A1 KPNB1	7.16e-05	989	145	14	36424410
Pubmed	FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.	MYC FBXW5 KDM6A	7.68e-05	20	145	3	32350066
Pubmed	KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer.	FLNA HNRNPU FASN ATP1A1 KPNB1	7.76e-05	104	145	5	36055981
Pubmed	CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).	UBR4 HNRNPU RBM25 KPNB1	8.38e-05	55	145	4	23178491
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	SERPINA3 COL6A2 PSAP LAMA1 OGN LOX ACAN	8.62e-05	248	145	7	24006456
Pubmed	Tagging genes with cassette-exchange sites.	CHERP TNPO2 UBR4 REST EZH2 RBCK1 RESF1 MMS19	8.65e-05	335	145	8	15741177
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TNPO1 FLNA FLNC CHERP UBR4 FASN RBM25 ANAPC1 SLC25A13 ATP1A1 KPNB1	9.82e-05	653	145	11	22586326
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF15 CACNA2D1 CHERP ECD INSR SMC6 GTF3C6 HNRNPU ORC1 FASN ANAPC1 HTATSF1 HSF2 TTC33 KPNB1	1.02e-04	1155	145	15	20360068
Pubmed	Cytokinesis of neuroepithelial cells can divide their basal process before anaphase.	LAMA1 PROM1	1.03e-04	4	145	2	18971946
Pubmed	Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.	MYC EZH2	1.03e-04	4	145	2	28914785
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNA FLNC	1.03e-04	4	145	2	11739414
Pubmed	The nucleoporin Nup98 is a site for GDP/GTP exchange on ran and termination of karyopherin beta 2-mediated nuclear import.	TNPO1 TNPO2	1.03e-04	4	145	2	10875935
Pubmed	Structural interaction and functional regulation of polycystin-2 by filamin.	FLNA FLNC	1.03e-04	4	145	2	22802962
Pubmed	Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.	NOX4 LOX	1.03e-04	4	145	2	18440230
Pubmed	Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins.	MYC PLXNA4	1.03e-04	4	145	2	15721238
Pubmed	Homocysteine induces podocyte apoptosis by regulating miR-1929-5p expression through c-Myc, DNMT1 and EZH2.	MYC EZH2	1.03e-04	4	145	2	34057794
Interaction	ASXL1 interactions	TNPO1 SERPINA3 FLNA EZH2 HNRNPU FASN SLC25A13 MMS19 ATP1A1 KDM6A KPNB1	5.21e-06	286	140	11	int:ASXL1
GeneFamily	Armadillo repeat containing\|Importins	TNPO1 TNPO2 KPNB1	1.38e-04	18	103	3	596
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CACNA2D1 SMC6 LAMA1 FHOD3 NLGN1 REV3L EZH2 TENM2 HNRNPU ORC1 PROM1 CCDC66 PLEKHM2 SLC25A13 PCDH11X ANKIB1 RIMS2 KDM6A KPNB1	3.35e-05	989	142	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	SMC6 FHOD3 CLSTN2 REV3L EZH2 TBC1D9 HNRNPU ORC1 PROM1 RBM25 CFAP54 CCDC66 PLEKHM2 ARHGAP44 MEPCE AP3M2 MMS19 ZNF518B FLRT3 PWWP3B HSF2 EFCAB7 KDM6A	3.92e-05	1370	142	23	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	CHERP OBSCN HNRNPU RESF1 NFATC3 KCNQ4 MEPCE KATNIP CFAP70 PLXNB1	1.78e-10	166	144	10	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A2 CACNA2D1 ADGRG6 PROM1 NEGR1 SPHKAP PCDH11X PLXNA4 PZP	1.84e-08	199	144	9	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A2 CACNA2D1 ADGRG6 PROM1 NEGR1 SPHKAP PCDH11X PLXNA4 PZP	1.92e-08	200	144	9	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 SPHKAP PCDH11X PLXNA4 PZP	1.92e-08	200	144	9	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 OBSCN FHOD3 OGN NEGR1 LOX UNC5C DSE	6.49e-08	164	144	8	a764b79a127c8f360af0b79a1da64658badf0dfa
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FHOD3 NLGN1 DNAH7 ADGRG6 AGBL4 PROM1 CFAP54 ALPK2	7.81e-08	168	144	8	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FHOD3 NLGN1 DNAH7 AGBL4 PROM1 CFAP54 NALF1 ALPK2	1.22e-07	178	144	8	544379f5a6145429762258d426b876bb36c112f5
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CACNA2D1 CLSTN2 REV3L OGN NFATC3 NEGR1 CYP7B1 ZNF518B	1.57e-07	184	144	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 FLNC OBSCN FHOD3 TENM2 FBN2 SPHKAP ALPK2	1.64e-07	185	144	8	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 OBSCN CLSTN2 REV3L CSMD2 FBN2 LOX DSE	1.85e-07	188	144	8	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NOX4 FHOD3 CLSTN2 NLGN1 ADGRG6 AGBL4 PROM1 ALPK2	1.93e-07	189	144	8	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	Control-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	MYC SERPINA3 COL6A2 NOX4 NLGN1 OGN NEGR1 LOX	2.55e-07	196	144	8	1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCell	18-Airway\|18 / Age, Tissue, Lineage and Cell class	INSR PROM1 FBN2 LOX ACAN NCOA7 ATP1A1 SYTL1	2.75e-07	198	144	8	3cdfcc6445858c3c54058bbd90b20b88b1771cca
ToppCell	distal-1-mesenchymal-Mesothelial\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A2 FLNC OGN TENM2 NALF1 LOX PWWP3B FAM110C	2.86e-07	199	144	8	8dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A2 LAMA1 COL6A5 REV3L OGN UNC5C PLXNA4 PZP	2.86e-07	199	144	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 SPHKAP PLXNA4 PZP	2.86e-07	199	144	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A2 ADGRG6 PROM1 NEGR1 SPHKAP PCDH11X PLXNA4 PZP	2.97e-07	200	144	8	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 SPHKAP PLXNA4 PZP	2.97e-07	200	144	8	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A2 LAMA1 COL6A5 REV3L OGN LPA PLXNA4 PZP	2.97e-07	200	144	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 ACAN PCDH11X PZP	2.97e-07	200	144	8	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC FHOD3 OGN TENM2 SPHKAP PWWP3B RIMS2	9.21e-07	160	144	7	8624f101828efd32cdd38a65df8d94d690720a63
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC FHOD3 OGN TENM2 SPHKAP PWWP3B RIMS2	9.21e-07	160	144	7	9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18
ToppCell	368C-Myeloid-Dendritic-pDC\|368C / Donor, Lineage, Cell class and subclass (all cells)	APOBEC3D CHERP TYSND1 NME8 PLXNA4 ANKIB1 ALPK2	1.23e-06	167	144	7	1e2fc1637769405a61f4c7e44945712a1888a299
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 FLNC NLGN1 OGN NALF1 PWWP3B FAM110C	1.81e-06	177	144	7	0912a291cff32a4ff8a2d7680ed1a1cd867fb90f
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 OBSCN COL6A5 FHOD3 FBN2 ARHGAP44 PZP	1.88e-06	178	144	7	5fc9f41609735b972a2cd0830182d13742cd5bf5
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 FLNC OBSCN FHOD3 TENM2 SPHKAP ALPK2	2.10e-06	181	144	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	COL6A2 CACNA2D1 FLNC NLGN1 OGN NALF1 FAM110C	2.26e-06	183	144	7	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC OBSCN FHOD3 TENM2 FBN2 SPHKAP ALPK2	2.34e-06	184	144	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	COL6A2 FLNC OGN LOX PLXNA4 PWWP3B FAM110C	2.34e-06	184	144	7	b0a251030d127858e68cf164be158f209a4d720f
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	COL6A2 FLNC NLGN1 OGN ADGRG6 NALF1 FAM110C	2.42e-06	185	144	7	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 ADGRG6 PROM1 CFAP54 FBN2 DNAI7 ALPK2	2.51e-06	186	144	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	COPD-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	MYC COL6A2 FLNC NLGN1 OGN NALF1 FAM110C	2.70e-06	188	144	7	159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	OBSCN FHOD3 NLGN1 TENM2 FBN2 SPHKAP ALPK2	2.79e-06	189	144	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Airway_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL6A2 COL6A5 OGN TENM2 NEGR1 LOX PCDH11X	2.79e-06	189	144	7	4f9608b84d135268a17455661870c46ae8554a24
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NOX4 FHOD3 CLSTN2 NLGN1 ADGRG6 AGBL4 ALPK2	2.79e-06	189	144	7	28b502611829e4a24caff2562545c7db97686099
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FLNA COL6A2 CACNA2D1 OGN ADGRG6 LOX PWWP3B	2.79e-06	189	144	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	FLNC OBSCN FHOD3 NLGN1 TENM2 FBN2 ALPK2	2.79e-06	189	144	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INSR NOX4 FHOD3 CLSTN2 NLGN1 AGBL4 ALPK2	2.89e-06	190	144	7	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 REV3L LOX UNC5C PLXNA4 CYP7B1	2.89e-06	190	144	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 FHOD3 OGN ADGRG6 PROM1 NEGR1 PLXNA4	2.99e-06	191	144	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 CACNA2D1 ADGRG6 PROM1 NEGR1 ACAN PZP	2.99e-06	191	144	7	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 CLSTN2 NLGN1 ADGRG6 AGBL4 PROM1 ALPK2	2.99e-06	191	144	7	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	NOX4 CLSTN2 REV3L NEGR1 SLC25A13 UNC5C NCOA7	2.99e-06	191	144	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN LOX UNC5C PLXNA4 CYP7B1	3.10e-06	192	144	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 REV3L UNC5C PLXNA4 CYP7B1 PZP	3.10e-06	192	144	7	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYC SERPINA3 COL6A2 CLSTN2 OGN NEGR1 CYP7B1	3.10e-06	192	144	7	d7faa993f68e530ad55185505384ae155d36c222
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN LOX UNC5C PLXNA4 PZP	3.10e-06	192	144	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN LOX UNC5C PLXNA4 PZP	3.10e-06	192	144	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A2 CLSTN2 NLGN1 OGN NEGR1 LOX UNC5C	3.10e-06	192	144	7	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN UNC5C PLXNA4 CYP7B1 PZP	3.10e-06	192	144	7	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN LOX UNC5C PLXNA4 CYP7B1	3.10e-06	192	144	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A2 CACNA2D1 NOX4 CSMD2 NEGR1 UNC5C CYP7B1	3.32e-06	194	144	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 FLNC OGN NALF1 PLXNA4 PWWP3B FAM110C	3.32e-06	194	144	7	c578cf7c6b4d6f31f87dde8845de5b3891f16822
ToppCell	IPF-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	COL6A2 FLNC NLGN1 OGN NALF1 PLXNA4 FAM110C	3.32e-06	194	144	7	d8a26da856a85e3d001d406e992cb18fdd58baef
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 FLNC OGN NALF1 PLXNA4 PWWP3B FAM110C	3.32e-06	194	144	7	f4286ae7bb8350c42d50727ee8688b80129714f6
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A5 OGN NEGR1 UNC5C PLXNA4 PZP	3.32e-06	194	144	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 FLNC OGN NALF1 PLXNA4 PWWP3B FAM110C	3.32e-06	194	144	7	87461bd6d7f702c0a0f5e0c8ace3049125a51f9a
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	INSR OBSCN FHOD3 TENM2 FBN2 SPHKAP ALPK2	3.43e-06	195	144	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A2 CACNA2D1 NLGN1 TENM2 ADGRG6 NALF1 UNC5C	3.43e-06	195	144	7	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 PSAP PFKFB2 GRIN2C REV3L SPHKAP SEZ6L	3.43e-06	195	144	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA2D1 CLSTN2 TENM2 AGBL4 NALF1 NEGR1 RIMS2	3.43e-06	195	144	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 PSAP PFKFB2 GRIN2C REV3L SPHKAP SEZ6L	3.43e-06	195	144	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OGN ADGRG6 NALF1 ARHGAP44 PLXNA4 PWWP3B FAM110C	3.67e-06	197	144	7	26888af95a7cc082a1f1218af35b1f07cb9436ed
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OGN ADGRG6 NALF1 ARHGAP44 PLXNA4 PWWP3B FAM110C	3.67e-06	197	144	7	438de7f0d35d81d5f5e41dcef7b2c54b6da03df4
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA2D1 FLNC TENM2 ADGRG6 LOX FLRT3 PLXNB1	3.80e-06	198	144	7	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA2D1 FLNC TENM2 ADGRG6 LOX FLRT3 PLXNB1	3.80e-06	198	144	7	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	COPD-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	MYC SERPINA3 COL6A2 NOX4 NLGN1 OGN NEGR1	3.80e-06	198	144	7	2f13c0b3372af53d1bd85f9546f315c878580a71
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM2 AGBL4 NALF1 NEGR1 ARHGAP44 PCDH11X RIMS2	3.80e-06	198	144	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA2D1 FLNC TENM2 ADGRG6 LOX FLRT3 PLXNB1	3.80e-06	198	144	7	5375a2895cf995f0db4a61861093f01794707901
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA2D1 FLNC TENM2 ADGRG6 LOX FLRT3 PLXNB1	3.80e-06	198	144	7	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	COPD-Stromal-Fibroblast\|COPD / Disease state, Lineage and Cell class	MYC SERPINA3 COL6A2 NOX4 OGN NEGR1 LOX	3.80e-06	198	144	7	7904af61473cb20064f7a3a1e1bfe8d5913cf317
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SERPINA3 COL6A2 COL6A5 OGN LOX UNC5C CYP7B1	3.92e-06	199	144	7	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	SMC6 REST REV3L USP16 GTF3C6 LOX CRYBG1	3.92e-06	199	144	7	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYC SERPINA3 COL6A2 COL6A5 REV3L OGN PZP	3.92e-06	199	144	7	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	INSR REST USP16 GTF3C6 RBM25 ANKIB1 NCOA7	3.92e-06	199	144	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYC COL6A2 NOX4 NLGN1 OGN NEGR1 LOX	3.92e-06	199	144	7	f835e7ffe976843b0edbf695762d463da85793f3
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYC COL6A2 NOX4 NLGN1 OGN NEGR1 LOX	3.92e-06	199	144	7	993fa050a095017135a6e723c77cd38b9d782e58
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SERPINA3 COL6A2 NOX4 OGN NEGR1 LOX UNC5C	4.06e-06	200	144	7	8d75ce89393df452defacf2ec9a5bd4b7708afbb
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A2 LAMA1 COL6A5 REV3L OGN PLXNA4 PZP	4.06e-06	200	144	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH7 AGBL4 PROM1 CFAP54 CFAP70 DNAI7 PZP	4.06e-06	200	144	7	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 PLXNA4 PZP	4.06e-06	200	144	7	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 ADGRG6 PROM1 NEGR1 PLXNA4 PZP	4.06e-06	200	144	7	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH7 AGBL4 PROM1 CFAP54 CFAP70 DNAI7 PZP	4.06e-06	200	144	7	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 NLGN1 CSMD2 OGN TENM2 ACAN PWWP3B	4.06e-06	200	144	7	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNA COL6A2 TENM2 ADGRG6 PROM1 ACAN PZP	4.06e-06	200	144	7	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SERPINA3 COL6A2 CACNA2D1 FLNC OGN LOX PWWP3B	4.06e-06	200	144	7	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FLNC LAMA1 ORC1 FBN2 LOX DSE	9.12e-06	149	144	6	3980fa4f1986a2f164a1826ea043fb71f1d756cd
ToppCell	IIH-Treg\|IIH / Condition, Cell_class and T cell subcluster	SLC24A5 EZH2 RESF1 GBP5 CYP7B1 TRAV13-1	1.06e-05	153	144	6	17704e18833812fcf2a2727b1e3f8a9984ba5b59
ToppCell	IIH-Treg-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	SLC24A5 EZH2 RESF1 GBP5 CYP7B1 TRAV13-1	1.10e-05	154	144	6	d2211a892654b92decb208969040920f7ae8ba1e
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A2 NOX4 COL6A5 NEGR1 UNC5C CYP7B1	1.27e-05	158	144	6	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SERPINA3 FHOD3 NLGN1 TBC1D9 NALF1 CRYBG1	1.32e-05	159	144	6	50d951cf27a571c0c5002003c16fbc370fa17eb1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 COL6A5 FBN2 SPHKAP UNC5C USH2A	1.37e-05	160	144	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 COL6A5 FBN2 SPHKAP UNC5C USH2A	1.37e-05	160	144	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Control-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	COL6A2 FLNC NLGN1 NALF1 ARHGAP44 FAM110C	1.69e-05	166	144	6	32ebaefa6c074b28193fff764ee7c2c0e9357e20
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA OBSCN NLGN1 TENM2 NME8 AJM1	1.69e-05	166	144	6	390cf5e56b72fcaf3b8520930bd35a3e3e173711
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA OBSCN NLGN1 TENM2 NME8 AJM1	1.69e-05	166	144	6	9a341dc7b756252caeaac1e934384911c880a634
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CLSTN2 CHRNA1 MROH8 SPHKAP PLXNA4	1.74e-05	167	144	6	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CLSTN2 CHRNA1 MROH8 SPHKAP PLXNA4	1.74e-05	167	144	6	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CLSTN2 CHRNA1 MROH8 SPHKAP PLXNA4	1.74e-05	167	144	6	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA2D1 CSMD2 AGBL4 SPHKAP RIMS2 SEZ6L	1.87e-05	169	144	6	b6b5bb6408c1305a00719e1b88a5e1202081faf3
Computational	Nuclear pore complex.	TNPO1 TNPO2 CLIC1 KPNB1	6.94e-06	17	82	4	MODULE_352
Disease	intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology)	TNPO1 TNPO2	2.08e-05	2	135	2	DOID:0081262 (implicated_via_orthology)
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNC	6.21e-05	3	135	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNC	6.21e-05	3	135	2	DOID:0111190 (implicated_via_orthology)
Disease	coronary restenosis (implicated_via_orthology)	MYC LOX	6.21e-05	3	135	2	DOID:4247 (implicated_via_orthology)
Disease	Colorectal Carcinoma	MYC FLNC LAMA1 OBSCN CLSTN2 PROM1 NCAPG FBN2 PCDH11X ATP11C PZP KDM6A	9.64e-05	702	135	12	C0009402
Disease	Hypertrophic Cardiomyopathy	MYC OBSCN FHOD3 FASN	1.37e-04	57	135	4	C0007194
Disease	adverse effect, response to xenobiotic stimulus	LAMA1 FHOD3 NLGN1 CYP7B1	1.57e-04	59	135	4	EFO_0009658, GO_0009410
Disease	Leukemia, Myelomonocytic, Chronic	EZH2 KDM6A	3.08e-04	6	135	2	C0023480
Disease	chronic lymphocytic leukemia (is_marker_for)	MYC PTPN22	7.32e-04	9	135	2	DOID:1040 (is_marker_for)
Disease	aortic stenosis, aortic valve calcification	MYSM1 ACAN LPA	9.44e-04	42	135	3	EFO_0000266, EFO_0005239
Disease	Osteosarcoma	MYC EZH2 LOX	1.31e-03	47	135	3	C0029463
Disease	Myasthenia gravis	PTPN22 CHRNA1	1.57e-03	13	135	2	EFO_0004991
Disease	Chromosome Breakage	MYC EZH2	1.82e-03	14	135	2	C0376628
Disease	Chromosome Breaks	MYC EZH2	1.82e-03	14	135	2	C0333704
Disease	malignant pleural mesothelioma (is_marker_for)	EZH2 KDM6A	1.82e-03	14	135	2	DOID:7474 (is_marker_for)
Disease	Familial thoracic aortic aneurysm and aortic dissection	FLNA FBN2 LOX	1.86e-03	53	135	3	C4707243
Disease	Drug habituation	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0013170
Disease	Drug abuse	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0013146
Disease	Prescription Drug Abuse	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C4316881
Disease	Substance-Related Disorders	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0236969
Disease	Drug Use Disorders	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0013222
Disease	Drug Dependence	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C1510472
Disease	Substance Dependence	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0038580
Disease	Substance Use Disorders	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	INSR FHOD3 TENM2 AGBL4	1.96e-03	115	135	4	C0029231
Disease	Substance abuse problem	INSR FHOD3 TENM2 AGBL4	2.02e-03	116	135	4	C0740858
Disease	Fetal Alcohol Syndrome	REST GABPA	2.70e-03	17	135	2	C0015923
Disease	late-onset myasthenia gravis	PTPN22 CHRNA1	3.03e-03	18	135	2	EFO_1001490
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	INSR EZH2 FASN	3.33e-03	65	135	3	DOID:0080208 (biomarker_via_orthology)
Disease	diabetic retinopathy	INSR NOX4 TENM2 MYSM1	3.59e-03	136	135	4	EFO_0003770
Disease	unipolar depression	CACNA2D1 NLGN1 DNAH7 TENM2 ANKRD27 ADGRG6 AGBL4 FASN NALF1 NEGR1 UNC5C CYP7B1 PZP	3.64e-03	1206	135	13	EFO_0003761
Disease	glycine measurement	TNPO1 INSR CLSTN2 KPNB1	3.68e-03	137	135	4	EFO_0009767
Disease	skin pigmentation measurement	SLC24A5 NOX4 RIMS2 USH2A	3.68e-03	137	135	4	EFO_0007009
Disease	prostate adenocarcinoma (is_implicated_in)	MYC INSR	3.74e-03	20	135	2	DOID:2526 (is_implicated_in)
Disease	ulcerative colitis, Crohn's disease	PTPN22 TTC33	3.74e-03	20	135	2	EFO_0000384, EFO_0000729
Disease	alpha-tocopherol measurement	CACNA2D1 USH2A	3.74e-03	20	135	2	EFO_0007898
Disease	dilated cardiomyopathy	FLNC FHOD3	3.74e-03	20	135	2	EFO_0000407
Disease	Benign Neoplasm	MYC FASN KDM6A	3.78e-03	68	135	3	C0086692
Disease	Neoplasms	MYC FASN KDM6A	3.78e-03	68	135	3	C0027651
Disease	bipolar disorder, body mass index	CLSTN2 NEGR1 AACS	4.44e-03	72	135	3	EFO_0004340, MONDO_0004985
Disease	serum IgM measurement	PTPN22 SIGLEC1	4.52e-03	22	135	2	EFO_0004993

Protein segments in the cluster

Peptide	Gene	Start	Entry
ASVEPYCADITSEEV	TADA3	156	O75528
VFFVESVCDDPDVIA	PFKFB2	151	O60825
YFVASPLQDEQSVIC	CFAP54	1046	Q96N23
FCDDILSPNTNYEVT	APOBEC3D	271	Q96AK3
CPVEYRSDVNSFVTE	CDS1	306	Q92903
FVIDYTENPRESCFD	CSMD2	1546	Q7Z408
ESFEEVEDSLCVPQY	AACS	561	Q86V21
IPYFRDEELSCTVVE	SERPINA3	251	P01011
CPEITLTYTEEFSDD	ALPK2	311	Q86TB3
FDIEEAPNCIYDSLS	ADGRG6	86	Q86SQ4
ESDFYEEIEVSCTPD	EVX1	116	P49640
NLYLFDETPVCIETE	FLRT3	486	Q9NZU0
EFPRVYEQLCEFVEA	AJM1	916	C9J069
YDCFQLVPVDIIESV	ANKIB1	381	Q9P2G1
ADAFDPEEYQFTCLT	ARIH2	51	O95376
YEVEASTFCFPESVD	CCM2	261	Q9BSQ5
PSSLCYVETVDIDGE	ATP8B3	261	O60423
VEAIDEDCSPQYSQI	CLSTN2	181	Q9H4D0
CNYEIVTTDVPFAID	CLSTN2	196	Q9H4D0
EDTVEYCLFLIPDES	ECD	11	O95905
EYIGEEEATLVDFVC	RBM25	781	P49756
TDESVVAEYIAPCST	PZP	1461	P20742
LLHVCYAPEFETVEE	RBM48	116	Q5RL73
DVRCYQEDDSVPICI	PTPN22	211	Q9Y2R2
PNELDSYFCDITQVV	OR4M2B	171	A0A0X1KG70
SYCEIIVTHFPFDEQ	CHRNA1	146	P02708
FSSVLYECVTQETPE	ANAPC1	1771	Q9H1A4
VVDTFQDYFGVCSEP	AP3M2	86	P53677
CQFESYILIPVEEHF	ANKRD27	51	Q96NW4
CKPCQYEAESEEQFV	REST	161	Q13127
VAGRFIEVPCSEDYD	OGFOD3	81	Q6PK18
VTLYTLVFEENPFCE	PASK	1191	Q96RG2
FSFDCEVAPNDVVSE	LINS1	691	Q8NG48
YECSAENDVSFPDVR	NEGR1	201	Q7Z3B1
DLVEAQTPEYDVVLC	MEPCE	566	Q7L2J0
VEELFEVTSCYFPID	MMS19	211	Q96T76
ECTEESIVEQTYAPA	GABPA	21	Q06546
SQEAEVSCPFIDNTY	RBCK1	316	Q9BYM8
CEAEYPEEDASAVLQ	KATNIP	331	O60303
CFLAYSIQAATEEEP	ATP1A1	111	P05023
EPAHYCSICEVEVFD	KDM6A	1326	O15550
APSEEVAEEKSYQCE	KCNQ4	506	P56696
TSDIQIFYQEDPECQ	DDX58	206	O95786
EFISEYCGEIISQDE	EZH2	636	Q15910
EEFQRLYDTVPCVEV	FBXW5	71	Q969U6
EDTAFNSYVEVPIGC	PLXNA4	286	Q9HCM2
IEYDVNSDCAQLPVD	PLXNB1	356	O43157
VPCAVDAQEYEVSSS	PLXNB1	1111	O43157
PNELDSYFCDITQVV	OR4M1	171	Q8NGD0
PNELDSYFCDITQVV	OR4M2	171	Q8NGB6
YPEDDIEETFCLNFT	HERC4	851	Q5GLZ8
TPSGAVEECYVSELD	FLNC	2446	Q14315
TLPEVAECFDEITYV	HNRNPU	641	Q00839
SGSVYCEEVDIDAVP	OGN	101	P20774
LLCFVSAYITDENPE	DSE	16	Q9UL01
LEPEFVQQVTEFCSY	GBP5	256	Q96PP8
FYPCTSEEIDHEDIT	IL12A	61	P29459
NQDTPEERCSVAAYV	INSR	826	P06213
EDCLYLNIYVPTEDV	NLGN1	151	Q8N2Q7
CFYEVEVAILPDEIF	PCDH11X	106	Q9BZA7
EEVVIPCAYDSDSES	MROH8	11	Q9H579
IDSERNPSEYVVCFL	C17orf75	141	Q9HAS0
ECDVTDDITATVPYN	IL20RB	96	Q6UXL0
PFEESLNYEVSLCVA	NOX4	416	Q9NPH5
AICYTGEDFVDIPEN	ACAN	346	P16112
SVSFRDPEEADYCIQ	HTATSF1	316	O43719
EVQDGYPVSFDCVVT	OBSCN	5136	Q5VST9
ASTPEYTSCDDVEIE	RIMS2	551	Q9UQ26
DYPACDSNINAETII	ORC1	116	Q13415
FDAIFVDEAQDCTPA	FBH1	641	Q8NFZ0
SVAYCLQTVTEDNPE	HEATR3	206	Q7Z4Q2
YITDVIDAEPFIRCS	KLHL12	231	Q53G59
VVPIYCTSFLAVEED	CHERP	241	Q8IWX8
ELTEACPFVIDIYAE	EFCAB7	496	A8K855
PDVCFDNNVLEDYTD	CACNA2D1	1056	P54289
PSGALEECYVTEIDQ	FLNA	2371	P21333
QAEIFFEDATCLEPT	CFAP70	721	Q5T0N1
EECPVYLEFDLVTYN	COL6A5	2351	A8TX70
TDCPIHVYFVLDTSE	COL6A2	41	P12110
SEPDYVRTLENCIQF	DNAH7	3016	Q8WXX0
LPDQDTFYDVVDCLE	FHOD3	276	Q2V2M9
VSEFEYDLFIRPDTC	AGBL4	61	Q5VU57
YFCVSPDTQELADVS	CCDC66	391	A2RUB6
PDFFEDNVVDLCQFT	DNAI7	366	Q6TDU7
EQALTEETPGVQDCY	LPA	1041	P08519
DVADDQEEPATYCLS	KPNB1	486	Q14974
VPESDYTNNVVRCDI	LOX	386	P28300
DTAELYPFCSSIIFE	CYP7B1	176	O75881
IYSEPDVSEKCIEVF	CRYBG1	1026	Q9Y4K1
VDEENALSPEACYEC	FBN2	2751	P35556
SEDCLVLNVYSPAEV	CES3	121	Q6UWW8
TREACPELDYFVVFS	FASN	2006	P49327
DTFFQYCGLDPEVVE	FAM110C	216	Q1W6H9
FSDYDIVILEVCPET	DCAF15	471	Q66K64
SNCSQYPDIVIVEDD	HSF2	276	Q03933
LQSYFAACEDEIPAI	PLEKHM2	21	Q8IWE5
DVIECSLQFPDDDYS	OPRK1	206	P41145
SLDTYVQCFVLPDDS	SYTL1	441	Q8IYJ3
DLSPFTIYDIQVEVC	USH2A	3076	O75445
PDIYCITDFAEELAD	SPHKAP	921	Q2M3C7
EEAVCAICLDYFTDP	TRIM41	16	Q8WV44
DPTYNIGTIVEFTCD	SEZ6L	581	Q9BYH1
YEDTLGTCVIFEENV	GTF3C6	66	Q969F1
TCSYYEDEDEEVLPV	NCOA7	761	Q8NI08
RFTPCIETYFEDEDQ	PWWP3B	591	Q5H9M0
CSSAAIQEDIYPQEI	RESF1	1011	Q9HCM1
VNQSFICDPDDETFI	MYC	111	P01106
AQAVVYCTCSVFPEE	NSUN7	431	Q8NE18
YCTCSVFPEENEAVV	NSUN7	436	Q8NE18
AFPEQCVVDAALEYV	LAMA1	2696	P25391
FCASVPEIAAQEEAY	PRR23B	141	Q6ZRT6
DTAVDVFLCSYIIDP	PROM1	776	O43490
DAVVSVGFEYETCPS	TENM2	1141	Q9NT68
QVFCSVYCVESDLPE	RNF217	161	Q8TC41
IQETEDAIGYCLTFE	PPP1R15B	676	Q5SWA1
LDCCVVDVQEYSADP	ARHGAP44	306	Q17R89
PVVYVDDSAILDCQF	SPRYD7	161	Q5W111
QEFVAFESVLCAPDA	SLC25A13	76	Q9UJS0
STCPDDEEIELAYEQ	CLIC1	221	O00299
ECPVVNAYATLIEND	NCAPG	176	Q9BPX3
PVSETEAYIAQRFCD	ATP11C	31	Q8NB49
LFSYKCQVDETEEPD	TPRA1	291	Q86W33
YEVVNEDPETAFCTL	USP16	606	Q9Y5T5
EVSEESPCESVQELY	NME8	141	Q8N427
VEEAIEYFPESLCAQ	NME8	406	Q8N427
DHDLSETIYQEPFCS	REV3L	1896	O60673
FATLEEEACTELVPY	TNPO2	501	O14787
EATQYFFEDITPECT	TBC1D9	951	Q6ZT07
CEHIYEFPQLSEDVI	UNC119B	201	A6NIH7
VCDEYFLPSLEIISE	SLC24A5	86	Q71RS6
LEPDDCASIYIFNVD	NFATC3	36	Q12968
IAESPFRCLDEFDVY	SMC6	1006	Q96SB8
LEGTEVDFNCSTPYV	SIGLEC1	151	Q9BZZ2
FANVYLADLTEEDPC	STIMATE	86	Q86TL2
CDQFVAEYEPVLIEI	PSAP	451	P07602
EEEACTELVPYLAYI	TNPO1	516	Q92973
EAELIFLEESPDYCT	WNT8A	246	Q9H1J5
EEDCFSLFPLETLVY	TRMT10B	196	Q6PF06
CSIIYPEENEVTEFF	UBR4	4336	Q5T4S7
VCASVPEIAAEEEAY	PRR23C	141	Q6ZRP0
EENFTTPCYIQLDAE	UNC5C	641	O95185
RVVFATQETCPYDIA	TYSND1	396	Q2T9J0
ITETQPEDSAVYFCA	TRAV13-1	96	A0A0B4J241
IPDYDFESDEIVAVC	TTC33	201	Q6PID6
YQVVDSLPDDSSQCV	ZNF518B	1021	Q9C0D4
VDTPLAAFFQDCISE	ATP6V0D1	156	P61421
EVETEPFLTYVEGVC	KCNC3	341	Q14003
CTGLYETFLTNDEPE	NALF1	361	B1AL88
YSEVDKVVEVCAAEP	MYSM1	606	Q5VVJ2
APVFVAYCSREEAEV	GRIN2C	221	Q14957